Skip to main content Help with accessibility Skip to main navigation

TOFACITINIB film-coated tablets (Xeljanz®▼) for moderately to severely active Ulcerative Colitis

CCG Approval Status:

Date Added: 31 - Jan - 2019
Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of TOFACITINIB film-coated tablets (Xeljanz®▼), by specialists only, for moderately to severely active Ulcerative Colitis in accordance with NICE TA547.